Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease

Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic mutations that drive disease.
The system predicts how DNA changes disrupt gene regulation across different tissues and cell types.
AlphaGenome can analyse up to one million DNA letters at once.
Researchers trained it on public human and mouse genetics databases.
The tool targets mutations linked to cancer, heart disease, autoimmune disorders, and mental health conditions.
Scientists say it could speed up drug discovery and gene therapy design.
Experts describe AlphaGenome as a major step toward understanding the non-coding genome.